GHK-Cu
Copper Tripeptide — Wound Healing, Skin Anti-Aging & Collagen Synthesis
Anti-Aging & Tissue Repair
Version 2025-04 · Last Reviewed April 1, 2025
About this review (v2025-04, last reviewed April 1, 2025): This review was compiled from published preclinical and clinical research, FDA regulatory documents, and compounding pharmacy guidance. No peptide vendor or manufacturer reviewed or approved this content. Read our full methodology
Educational content only. This page reflects published research and does not constitute medical advice. Peptides are not FDA-approved drugs (with limited exceptions noted). Consult a licensed healthcare provider before use. Dosing is intentionally omitted — it is determined by your provider based on individual labs and goals.
What it is
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It is one of the most studied peptides in regenerative biology. Its plasma concentration declines with age — from roughly 200 ng/mL at age 20 to below 80 ng/mL by age 60. In both laboratory and animal studies, GHK-Cu activates a broad regenerative gene expression program, promotes collagen and elastin synthesis, stimulates wound healing, and shows anti-fibrotic, antioxidant, and potentially anti-inflammatory effects.
Regulatory status
GHK-Cu is not FDA-approved as a drug. It is widely used as a cosmetic ingredient in topical skincare products, which do not require FDA drug approval. For use as an injectable, compounding pharmacies can compound it under physician prescription. No WADA scheduling.
Mechanism of Action
GHK-Cu activates over 4,000 human genes based on gene expression studies — more than any other known peptide of its size. Key mechanisms include upregulation of collagen and elastin synthesis, promotion of proteoglycan production (structural components of skin and connective tissue), stimulation of angiogenesis, modulation of TGF-β (transforming growth factor beta — a key driver of both healing and fibrosis), antioxidant gene upregulation, and anti-apoptotic signaling. The copper ion itself is a cofactor for key enzymes including lysyl oxidase (essential for collagen cross-linking) and superoxide dismutase (SOD, a major antioxidant enzyme).
What Research Has Explored
These are areas of published research — not personal recommendations.
Wound healing and skin repair (topical)
GHK-Cu applied topically has shown acceleration of wound closure in human studies. It is the most evidence-supported application, particularly for dermal wounds, skin aging, and post-procedure skin healing.
Context: This is the best-evidenced application with the most legitimate delivery route. Many prescription wound care products and cosmetic serums incorporate GHK-Cu for this purpose.
Skin anti-aging
Topical GHK-Cu has shown improvements in skin elasticity, density, and wrinkle depth in small human trials, likely through collagen and glycosaminoglycan stimulation.
Context: Studies are generally small and some are industry-funded. Effect sizes are real but not dramatic. This is not a pharmaceutical — manage expectations accordingly.
Hair growth
GHK-Cu has been studied for follicle stimulation in animal models and small human trials. It may increase follicle size and stimulate hair growth, possibly through TGF-β modulation.
Context: Evidence is preliminary. Not a validated hair loss treatment in the way FDA-approved options (minoxidil, finasteride) are.
Systemic anti-fibrotic effects (injectable)
Animal studies suggest injectable GHK-Cu may reduce organ fibrosis (lung, liver) by modulating TGF-β. Gene expression studies show anti-fibrotic gene activation.
Context: Systemic effects from topical application are not supported by evidence. Injectable administration for systemic anti-fibrotic effects is experimental and outside any approved framework.
Stability & Delivery Form — Why This Matters
Most peptides are fragile molecules destroyed by stomach acid and digestive enzymes. Delivery form determines whether the peptide survives to reach your bloodstream.
Capsule / Pill Warning
GHK-Cu in capsule or pill form has no meaningful systemic bioavailability. Stomach acid and digestive enzymes destroy the peptide bonds before absorption. If a product is sold as a capsule claiming the systemic effects of the injectable form, it cannot deliver those effects. This is a red flag about the vendor's credibility.
Topical serum or cream
Legitimate and widely available for skin-specific effects. GHK-Cu is small enough to penetrate the stratum corneum. This is the most evidence-supported and lowest-risk delivery route. Look for products listing 'copper tripeptide-1' or 'GHK-Cu' in the ingredients.
Subcutaneous injection (compounded)
Used for claims of systemic anti-aging, fibrosis reduction, or systemic tissue repair. This application is experimental and lacks human clinical data. If considering, only through a licensed compounding pharmacy and physician.
Oral capsule
GHK-Cu is a tripeptide rapidly degraded by GI peptidases. Oral capsules cannot deliver intact GHK-Cu systemically. Any product claiming oral systemic GHK-Cu effects is not supported by pharmacology.
Dosing is intentionally not listed here. It is determined by your provider based on individual labs, goals, and clinical context.
Frequently Asked Questions About GHK-Cu
- What is GHK-Cu?
- GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It is one of the most studied peptides in regenerative biology. Its plasma concentration declines with age — from roughly 200 ng/mL at age 20 to below 80 ng/mL by age 60. In both laboratory and animal studies, GHK-Cu activates a broad regenerative gene expression program, promotes collagen and elastin synthesis, stimulates wound healing, and shows anti-fibrotic, antioxidant, and potentially anti-inflammatory effects.
- What is GHK-Cu used for in research?
- GHK-Cu has the most legitimate topical evidence of any peptide in this section — with real human wound healing and skin aging data — but systemic injectable claims extrapolate far beyond what clinical research has established. Research areas include: Wound healing and skin repair (topical), Skin anti-aging, Hair growth.
- Is GHK-Cu FDA approved?
- GHK-Cu is not FDA-approved as a drug. It is widely used as a cosmetic ingredient in topical skincare products, which do not require FDA drug approval. For use as an injectable, compounding pharmacies can compound it under physician prescription. No WADA scheduling.
- How is GHK-Cu administered?
- Topical (skin applications) or subcutaneous injection (systemic applications — experimental)
- What are the safety risks of sourcing GHK-Cu?
- Key risks when sourcing GHK-Cu from grey-market or research suppliers include: For topical use, the primary risk of unverified products is incorrect concentration, contamination with other ingredients, or degraded peptide. Quality cosmetic brands perform stability testing; random grey market sellers do not.; For injectable GHK-Cu specifically, standard endotoxin contamination and sterility risks apply. These are manageable with a licensed compounding pharmacy.; GHK-Cu's broad gene activation profile is generally considered favorable in animal models, but injecting large quantities of a compound that activates thousands of genes without clinical monitoring is not without theoretical risk..
- Who should avoid or be cautious about GHK-Cu?
- GHK-Cu should be used with caution or avoided by: Wilson's disease or genetic copper metabolism disorders — GHK-Cu is a copper complex; consult specialist before any use.; Pregnancy and breastfeeding — no safety data for injectable use.; Cancer — GHK-Cu activates broad gene expression programs including angiogenic genes; theoretical concern with active malignancy..
Stay informed — get updates when we add new medications
We add new medications and supplements regularly. No spam, ever.
No spam. Unsubscribe anytime.